微创医疗(00853)上涨2.38%，报14.64元/股

Core Viewpoint - MicroPort Medical is a multinational enterprise focused on innovative medical technologies across various fields, including cardiovascular, cerebrovascular, nervous system, and orthopedics, aiming to provide accessible medical solutions [1][2]. Group 1: Company Performance - As of the 2024 annual report, MicroPort Medical reported total revenue of 7.412 billion yuan and a net loss of 1.539 billion yuan [2]. Group 2: Market Activity - On July 31, MicroPort Medical's stock price increased by 2.38%, reaching 14.64 yuan per share, with a trading volume of 330 million yuan [1].